FDA Person
Office of the CommissionerMarvin D. Jones
View detailed information about Marvin D. Jones, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner. Took part in 60 inspections of 60 companies, 2016–2026.
Inspections (60)
See all 60 inspections in the dashboard
Documents (38)
- 483 · People's Custom Rx and Clinical Care, LLC · August 5, 2021
- 483 · PharMEDium Services, LLC. · February 22, 2013
- 483 · Vital Care of Dickson, LLC · March 11, 2020
- 483 · PharMEDium Services, LLC. · January 5, 2018
- 483 · Baxter Healthcare Corporation · January 23, 2014
- 483 · Compounding Pharmacy of America · May 21, 2015
- 483 · Delta Pharma, Inc. · May 24, 2016
- 483 · Vital Care Compounder, Inc · July 7, 2016
- 483 · Baxter Healthcare Corporation · February 5, 2010
- 483 · Coastal Meds, LLC · November 10, 2014
- 483 · Central Admixture Pharmacy Services, Inc. · January 19, 2007
- 483 · Main Street Family Pharmacy, LLC · June 11, 2013
- 483 · Pharmedium Services, LLC · March 22, 2013
- 483 RESPONSE · People's Custom Rx and Clinical Care, LLC · August 5, 2021
- 483 RESPONSE · Compounding Pharmacy of America · May 15, 2015
- EIR · Exxonmobil Product Solutions Company · April 21, 2016
- EIR · The Procter & Gamble Manufacturing Company · March 10, 2023
- 483 · Pharmaron (Ningbo) Technology Development Co. Ltd. · November 1, 2024
- 483 · Sichuan Huiyu Pharmaceutical Co., Ltd. · November 6, 2025
- 483 · Pharmaron (Ningbo) Technology Development Co., Ltd. · November 1, 2024
- 483 · Xinyu Pharmaceutical Co., Ltd. · June 27, 2025
- 483 · Qilu SYNVA Pharmaceutical Co. Ltd · May 16, 2025
- 483 · Liuzhou Liangmianzhen (LMZ) Co., Ltd. · March 22, 2024
- EIR · Yichang Sanxia Pharmaceutical Co., Ltd. · September 8, 2023
- 483 · Shouguang Fukang Pharmaceutical Co., Ltd. · February 21, 2025
- 483 · Shanghai SynTheAll Pharmaceutical Co., Ltd. · April 25, 2025
- 483 · Quality CDMO · June 16, 2023
- 483 · Oxford Pharmaceuticals, LLC · November 3, 2023
- 483 · Sircle Laboratories, L.L.C. · April 26, 2021
- 483 · ABC Compounding Co., Inc. · April 21, 2023
- EIR · Shandong Xinhua Pharmaceutical Co., Ltd. · September 15, 2023
- 483 · Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) · December 15, 2025
- 483 · Henan Lvyuan Pharmaceutical Co., Ltd. · September 26, 2025
- 483 · Promise Pharmacy, LLC · September 23, 2021
- 483 · Qilu Pharmaceutical (Hainan) Co. Ltd. · August 22, 2025
- 483 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) · July 3, 2026
- 483 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) · July 16, 2026
- 483 · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · April 9, 2026
Frequently inspected with (10)
Jason D. Tenney
Investigator
5 shared
Martrice A. Packer
Program Coordinator
3 shared
Matthew R. Mcnew
3 shared
Tsz Kwan K. Ngan
3 shared
Wayne S. Fortenberry
Printwraps
3 shared
Arthur G. Hurst
investigator
2 shared
Audra J. Lenhart
2 shared
Eileen A. Liu
2 shared
Marcus A. Ray
Supervisory Consumer Safety Officer, China Office
2 shared
Michael L. Casner
investigator
2 shared
Related Office
Person Information
Name
Marvin D. Jones
Title
Investigator
Role
Regulatory Personnel
ID: 3101a8da-f5c1-4e0c-b4b1-b09be181be36
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.